Gene · 3663
Papers4,211
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,141 to 1,160 of 4,211
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Beyond Immunosuppression: The Multifaceted Functions of Tumor-Promoting Myeloid Cells in Breast Cancers. | Front Immunol | 2022 | 35309358 | PubTator, text mining | PubMed |
| A Systematic Review of Tissue and Single Cell Transcriptome/Proteome Studies of the Brain in Multiple Sclerosis. | Front Immunol | 2022 | 35309325 | PubTator, text mining | PubMed |
| Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity. | Front Immunol | 2022 | 35309296 | PubTator, text mining | PubMed |
| Identification of a Novel Survival-Related circRNA-miRNA-mRNA Regulatory Network Related to Immune Infiltration in Liver Hepatocellular Carcinoma. | Front Genet | 2022 | 35309118 | PubTator, text mining | PubMed |
| Baseline mapping of Oropouche virology, epidemiology, therapeutics, and vaccine research and development. | NPJ Vaccines | 2022 | 35301331 | PubTator, text mining | PubMed |
| Therapeutic targeting miR130b counteracts diffuse large B-cell lymphoma progression via OX40/OX40L-mediated interaction with Th17 cells. | Signal Transduct Target Ther | 2022 | 35301282 | PubTator, text mining | PubMed |
| Molecular identification and functional characterization of IRF4 from common carp (Cyprinus carpio. L) in immune response: a negative regulator in the IFN and NF-κB signalling pathways. | BMC Vet Res | 2022 | 35300694 | PubTator, text mining | PubMed |
| BTG2 Serves as a Potential Prognostic Marker and Correlates with Immune Infiltration in Lung Adenocarcinoma. | Int J Gen Med | 2022 | 35300128 | PubTator, text mining | PubMed |
| FAT10 is a Prognostic Biomarker and Correlated With Immune Infiltrates in Skin Cutaneous Melanoma. | Front Mol Biosci | 2022 | 35300113 | PubTator, text mining | PubMed |
| Type I interferon-mediated tumor immunity and its role in immunotherapy. | Cell Mol Life Sci | 2022 | 35292881 | PubTator, text mining | PubMed |
| Effect of stimulation time on the expression of human macrophage polarization markers. | PLoS One | 2022 | 35286356 | PubTator, text mining | PubMed |
| Microglial Activation Modulated by P2X4R in Ischemia and Repercussions in Alzheimer's Disease. | Front Physiol | 2022 | 35283778 | PubTator, text mining | PubMed |
| Analysis of the long non-coding RNA and mRNA expression profiles associated with lidocaine-induced neurotoxicity in the spinal cord of a rat model. | Neurotoxicology | 2022 | 35283115 | PubTator, text mining | PubMed |
| High Expression of RRM1 Mediated by ncRNAs Correlates with Poor Prognosis and Tumor Immune Infiltration of Hepatocellular Carcinoma. | Int J Gen Med | 2022 | 35282644 | PubTator, text mining | PubMed |
| Systemic Lupus Erythematosus and Cardiovascular Disease. | Cureus | 2022 | 35282557 | PubTator, text mining | PubMed |
| The expression of HOXC10 is correlated with tumor-infiltrating immune cells in basal-like breast cancer and serves as a prognostic biomarker. | Ann Transl Med | 2022 | 35282072 | PubTator, text mining | PubMed |
| Restoration of Default Blood Monocyte-Derived Macrophage Polarization With Adalimumab But Not Etanercept in Rheumatoid Arthritis. | Front Immunol | 2022 | 35281074 | PubTator, text mining | PubMed |
| P2RY14 downregulation in lung adenocarcinoma: a potential therapeutic target associated with immune infiltration. | J Thorac Dis | 2022 | 35280459 | PubTator, text mining | PubMed |
| Downregulation of ZC3H13 by miR-362-3p/miR-425-5p is associated with a poor prognosis and adverse outcomes in hepatocellular carcinoma. | Aging (Albany NY) | 2022 | 35278064 | PubTator, text mining | PubMed |
| Modulation of Type I Interferon Responses to Influence Tumor-Immune Cross Talk in PDAC. | Front Cell Dev Biol | 2022 | 35273962 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3663/papers?page=58